Skip to main content
. 2016 Mar 25;60(4):2425–2434. doi: 10.1128/AAC.01667-15

TABLE 4.

Results of acute toxicity analysisa

Compound Result after treatment at the following dose (mg/kg):
NOAEL (mg/kg)
0 12.5 25 50 100 200
35DAP073 NDE NDE NDE Loss of mouse body wt Tremors, ataxia Death 25
35DAP081 NDE Ataxia, tremors, excitation and vocalizationb Ataxia, tremors, excitation and vocalizationb Ataxia, tremors, excitation and vocalizationb Ataxia, tremors, excitation and vocalizationb Ataxia, tremors, excitation and vocalizationb <12. 5
a

Escalating doses starting at 12.5 mg/kg and increasing to 200 mg/kg were administered i.p. in a 0.1-ml final volume to female Swiss Webster mice, using a single mouse per dose. NOAEL, no-observed-adverse-effect level (for noninvasive parameters); NDE, no detectable effect.

b

These effects were observed after 2 h of compound administration.